ACCESSION: MSBNK-SMB_Measured-HSA001P0117005
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 18
COMMENT: RAW_SPEC {'BLK01_14668': {'bp': 82588.0, 'sum': 255705.0}, 'BLK01_14604': {'bp': 69087.0, 'sum': 215091.0}, '1_posi_15196': {'bp': 68865.0, 'sum': 203183.0}, 'ProcedureBlank_15254': {'bp': 68720.0, 'sum': 197538.0}, '1_posi_14970': {'bp': 64459.0, 'sum': 198805.0}, 'BLK02_14667': {'bp': 63721.0, 'sum': 211876.0}, 'ProcedureBlank_14775': {'bp': 62701.0, 'sum': 186817.0}, '1_posi_15110': {'bp': 61226.0, 'sum': 182138.0}, '1_posi_15278': {'bp': 60929.0, 'sum': 171576.0}, '1_posi_15047': {'bp': 60548.0, 'sum': 178648.0}, 'BLK02_14606': {'bp': 59856.0, 'sum': 185036.0}, '1_posi_14899': {'bp': 55286.0, 'sum': 156266.0}, 'ProcedureBlank_14584': {'bp': 54205.0, 'sum': 147333.0}, '1_posi_14797': {'bp': 53360.0, 'sum': 155574.0}, '2_posi_15171': {'bp': 53338.0, 'sum': 149224.0}, '2_posi_15090': {'bp': 53218.0, 'sum': 151983.0}, 'ProcedureBlank_14649': {'bp': 53169.0, 'sum': 163288.0}, '1_posi_14631': {'bp': 51464.0, 'sum': 149961.0}}
COMMENT: RETENTION_TIME_STDEV 0.513
COMMENT: PRECURSOR_M/Z_RAW 117.065777
COMMENT: PRECURSOR_M/Z_STDEV 0.000025
COMMENT: PRECURSOR_IN_MS1 mz 117.065795; int 40.002; delta(ppm) 1.405531
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+H; M+2ACN+H; mz 199.118969; int 5.452; cor 0.676
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.500; C4H8N2O2; [M+H]+; delta(ppm) -0.499748
COMMENT: PROPOSED_MF MS-FINDER 4.264; C4H8N2O2; [M+H]+; delta(ppm) -0.494985
COMMENT: PROPOSED_MF SIRIUS6_Sirius 11.863; C4H8N2O2; [M+H]+; delta(ppm) -0.494985
COMMENT: PROPOSED_MF SIRIUS6_Sirius -3.621; C2H6N5O; [M+H]+; delta(ppm) 10.974442
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C4H8N2O2; [M+H]+; delta(ppm) -0.494985
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.686; XDZKGLWJXJTZJZ-UHFFFAOYNA-N; [M+H]+; OC1CCN(C1)N=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.500; ZKXDGKXYMTYWTB-UHFFFAOYSA-N; [M+H]+; O=NN1CCOCC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.487; HCKUBNLZMKAEIN-UHFFFAOYSA-N; [M+H]+; C1CN(C(=O)C1N)O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.400; JGUQDUKBUKFFRO-GGWOSOGESA-N; [M+H]+; C\C(=N/O)\C(\C)=N\O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.400; WTPHDERCPWEBOS-UHFFFAOYSA-N; [M+H]+; CC(C(C)N=O)N=O
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.813; ZLHNYIHIHQEHJQ-UHFFFAOYSA-N; [M+H]+; N,N'-Diacetylhydrazine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.604; ZKXDGKXYMTYWTB-UHFFFAOYSA-N; [M+H]+; N-nitrosomorpholine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.552; SNCZNSNPXMPCGN-UHFFFAOYSA-N; [M+H]+; Succinamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.500; XDZKGLWJXJTZJZ-UHFFFAOYNA-N; [M+H]+; N-Nitroso-3-hydroxypyrrolidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.500; JGUQDUKBUKFFRO-GGWOSOGESA-N; [M+H]+; UNPD25328
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.448; IPZCJUOJSODZNK-UHFFFAOYSA-N; [M+H]+; UNPD20580
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.396; CQGSPCLZUXSVHE-UHFFFAOYSA-N; [M+H]+; 3-(N-Nitrosomethylamino)propionaldehyde
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.396; FVRHIJPPPSYMGI-UHFFFAOYSA-N; [M+H]+; 3-amino-4-oxobutanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.396; HCKUBNLZMKAEIN-UHFFFAOYSA-N; [M+H]+; 3-amino-1-hydroxypyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.396; WTPHDERCPWEBOS-UHFFFAOYSA-N; [M+H]+; 2,3-dinitrosobutane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.396; CGRKYGKHZOCPSZ-UHFFFAOYSA-N; [M+H]+; 2-methylpropanediamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.396; GBGBFESMVVCWBU-UHFFFAOYSA-N; [M+H]+; CNP0432065
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.396; XRVHSOXXNQTWAW-UHFFFAOYSA-N; [M+H]+; 1-acetyl-3-methylurea
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; FVRHIJPPPSYMGI-UHFFFAOYSA-N; [M+H]+; 3-amino-4-oxobutanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.905; HCKUBNLZMKAEIN-UHFFFAOYSA-N; [M+H]+; 3-amino-1-hydroxypyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.869; CQGSPCLZUXSVHE-UHFFFAOYSA-N; [M+H]+; 3-(N-Nitrosomethylamino)propionaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.751; XDZKGLWJXJTZJZ-UHFFFAOYNA-N; [M+H]+; N-Nitroso-3-hydroxypyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.748; ZKXDGKXYMTYWTB-UHFFFAOYSA-N; [M+H]+; N-nitrosomorpholine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; ZLHNYIHIHQEHJQ-UHFFFAOYSA-N; [M+H]+; N,N'-Diacetylhydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; SNCZNSNPXMPCGN-UHFFFAOYSA-N; [M+H]+; Succinamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; IPZCJUOJSODZNK-UHFFFAOYSA-N; [M+H]+; UNPD20580
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; JGUQDUKBUKFFRO-GGWOSOGESA-N; [M+H]+; UNPD25328
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; WTPHDERCPWEBOS-UHFFFAOYSA-N; [M+H]+; 2,3-dinitrosobutane
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; CGRKYGKHZOCPSZ-UHFFFAOYSA-N; [M+H]+; 2-methylpropanediamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; GBGBFESMVVCWBU-UHFFFAOYSA-N; [M+H]+; CNP0432065
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; XRVHSOXXNQTWAW-UHFFFAOYSA-N; [M+H]+; 1-acetyl-3-methylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.842; ZKXDGKXYMTYWTB-UHFFFAOYSA-N; [M+H]+; 4-nitrosomorpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.017; HCKUBNLZMKAEIN-UHFFFAOYSA-N; [M+H]+; 3-amino-1-hydroxypyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.520; SNCZNSNPXMPCGN-UHFFFAOYSA-N; [M+H]+; butanediamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.240; CQGSPCLZUXSVHE-UHFFFAOYSA-N; [M+H]+; N-methyl-N-(3-oxopropyl)nitrous amide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.169; PISNODKEJUFUNQ-UHFFFAOYSA-N; [M+H]+; 3-amino-1,3-oxazinan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.133; XDZKGLWJXJTZJZ-UHFFFAOYSA-N; [M+H]+; 1-nitrosopyrrolidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.126; JVQJUHZAZCBYPP-UHFFFAOYSA-N; [M+H]+; 3-nitroso-1,3-oxazinane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.091; JDXWVZWFFCLGPU-GSVOUGTGSA-N; [M+H]+; (4R)-4-(hydroxymethyl)imidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.084; HUHZAMBLEKHDBP-UHFFFAOYSA-N; [M+H]+; 5-(aminomethyl)-1,3-oxazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.064; SEMURSKJWYPYKW-UHFFFAOYSA-N; [M+H]+; 4-(aminomethyl)-1,3-oxazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.052; NBNDPGGJEJRDBJ-UHFFFAOYSA-N; [M+H]+; N-(2-formamidoethyl)formamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.028; OYFXZONQZDQAMM-UHFFFAOYSA-N; [M+H]+; N-(1-formamidoethyl)formamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.999; PZSCGIVZIUKDAJ-UHFFFAOYSA-N; [M+H]+; 5-hydroxy-1,3-diazinan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.992; GUXPHGONOMGJLV-UHFFFAOYSA-N; [M+H]+; 3-hydroxyazetidine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.991; UJKOPPMEGDPMLI-GBXIJSLDSA-N; [M+H]+; (3S,4R)-3-amino-4-hydroxypyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.986; PREXGTBZMLDXHV-UHFFFAOYSA-N; [M+H]+; 2-nitrosooxazinane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.965; XNOOYCHPRQVDCU-UHFFFAOYSA-N; [M+H]+; 5-methyl-3-nitroso-1,3-oxazolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.958; KCYALJYRNPZWCX-UHFFFAOYSA-N; [M+H]+; 1-nitrosopyrrolidin-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.946; SKBRWWAAKYUZEW-UHFFFAOYSA-N; [M+H]+; 4-amino-2-methyl-1,2-oxazolidin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.735; ZLHNYIHIHQEHJQ-UHFFFAOYSA-N; [M+H]+; N'-acetylacetohydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.379; CWULQTRBZMJZEG-UHFFFAOYSA-N; [M+H]+; N-methyl-N-(2-oxopropyl)nitrous amide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.218; WQELDIQOHGAHEM-UHFFFAOYSA-N; [M+H]+; 2-acetamidoacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.192; XRVHSOXXNQTWAW-UHFFFAOYSA-N; [M+H]+; N-(methylcarbamoyl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.187; IPZCJUOJSODZNK-UHFFFAOYSA-N; [M+H]+; N,N'-dimethyloxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.182; CGRKYGKHZOCPSZ-UHFFFAOYSA-N; [M+H]+; 2-methylpropanediamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.177; KKACJTWOOFIGAD-UHFFFAOYSA-N; [M+H]+; N-carbamoylpropanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.176; JKOVQYWMFZTKMX-ONEGZZNKSA-N; [M+H]+; (E)-N,N-dimethyl-2-nitroethenamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.174; SAMSRYBWUYCCEM-UHFFFAOYSA-N; [M+H]+; ethyl 2-amino-2-iminoacetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.169; GFVNJDIBQYYKGS-UHFFFAOYSA-N; [M+H]+; azetidin-3-yl carbamate
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C4H9N2O2; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 29.888
MS$FOCUSED_ION: PRECURSOR_M/Z 117.065796
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0fk9-9700000000-a21d7c5d66401fc9741b
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  71.0603079 74.7972 71.060921 1.8857 22.00 0.7049 18 f{C3H7N2}/-0.94ppm,p-C1H2O2
  72.0444213 999.0000 72.045028 0.3748 33.28 0.4923 18 f{C3H6N1O1}/0.43ppm,p-C1H3N1O1
  72.0807176 157.2734 72.081324 0.9573 38.54 0.3086 18 ?
  74.0963726 104.8187 74.096964 1.0392 25.58 0.3498 18 ?
  99.0552873 118.5911 99.055617 1.4134 20.77 0.0980 18 f{C4H7N2O1}/-0.02ppm,p-H2O1
  100.0757622 118.1434 100.076083 1.7387 29.21 -0.1022 18 ?
  100.1121292 724.8889 100.112450 0.5194 139.45 0.5335 18 ?
  117.0659384 149.4443 117.066085 1.5718 26.02 1.0000 18 f{C4H9N2O2}/0.72ppm,p
  117.1025151 80.8923 117.102661 1.1358 15.09 0.1786 15 ?
  117.1104345 90.7858 117.110581 1.9640 17.96 0.1311 18 ?
  117.1386272 107.7949 117.138773 2.2794 30.19 0.7721 17 ?
PK$NUM_PEAK: 11
PK$PEAK: m/z int. rel.int.
  71.060308 74.80 74
  72.044421 999.00 999
  72.080718 157.27 157
  74.096373 104.82 104
  99.055287 118.59 118
  100.075762 118.14 118
  100.112129 724.89 724
  117.065938 149.44 149
  117.102515 80.89 80
  117.110435 90.79 90
  117.138627 107.79 107
//
